Jan 09, 2024 / 04:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Great. Thanks, everyone. We can get started here. If you want to take a seat. My name is Robbie Marcus. I'm the Medtech analyst at JPMorgan. Really happy to introduce our next session. I'm going to bring up Ivan Tornos, the CEO of Zimmer Biomet for a presentation, then we'll do some Q&A afterwards.
Ivan?
Ivan Tornos - Zimmer Biomet Holdings, Inc. - COO, President, CEO & Director
All right. Good morning. I was expecting some music, some ACDC and (inaudible), but I guess I'm not getting that today. Yes, thank you, Robbie. My name is Ivan Tornos. I'm the President and CEO of Zimmer Biomet. I've been with the company, 5 years. I've been in this job, 111 days and 2 hours. So I look forward to some questions later on.
But before we get started, I do want to thank you, Robbie, for hosting this decision. I want to thank, obviously, everybody for being here this morning. I want to thank my team. We got about 10 people here from Zimmer Biomet. I want to thank all of you
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot